BACKGROUND: Lung contusion (LC) is an independent risk factor for acute respiratory distress syndrome. The final common pathway in ARDS involves accumulation of fluid in the alveoli. In this study, we demonstrate the application of a potential gene therapy approach by delivering the Na+/K+-ATPase pump subunits in a murine model of LC. We hypothesized that restoring the activity of the pump will result in removal of excess alveolar fluid and additionally reduce inflammation. METHODS: Under anesthesia, C57/BL6 mice were struck along the right posterior axillary line 1 cm above the costal margin with a cortical contusion impactor. Immediately afterward, 100 μg of plasmid DNA coding for the α,β of the Na+/K+-ATPase pump were instilled into the lungs (LC-electroporation-pump group). Contusion only (LC-only) and a sham saline instillation group after contusion were used as controls (LC-electroporation-sham). By using a BTX 830 electroporator, eight electrical pulses of 200 V/cm field strength were applied transthoracically. Mice were killed at 24 hours, 48 hours, and 72 hours after delivery. Bronchial alveolar lavage was recollected to measure albumin and cytokines by enzyme-linked immunosorbent assay. Pulmonary compliance was measured, and lungs were subject to histopathologic analysis. RESULTS: After the electroporation and delivery of genes coding for the α,β subunits of the Na+/K+-ATPase pump, there was a significant mitigation of acute lung injury as evidenced by reduction in bronchial alveolar lavage levels of albumin, improved pressure volume curves, and reduced inflammation seen on histology. CONCLUSION: Electroporation-mediated gene transfer of the subunits of the Na+/K+-ATPase pump enhanced recovery from acute inflammatory lung injury after LC.
BACKGROUND: Lung contusion (LC) is an independent risk factor for acute respiratory distress syndrome. The final common pathway in ARDS involves accumulation of fluid in the alveoli. In this study, we demonstrate the application of a potential gene therapy approach by delivering the Na+/K+-ATPase pump subunits in a murine model of LC. We hypothesized that restoring the activity of the pump will result in removal of excess alveolar fluid and additionally reduce inflammation. METHODS: Under anesthesia, C57/BL6mice were struck along the right posterior axillary line 1 cm above the costal margin with a cortical contusion impactor. Immediately afterward, 100 μg of plasmid DNA coding for the α,β of the Na+/K+-ATPase pump were instilled into the lungs (LC-electroporation-pump group). Contusion only (LC-only) and a sham saline instillation group after contusion were used as controls (LC-electroporation-sham). By using a BTX 830 electroporator, eight electrical pulses of 200 V/cm field strength were applied transthoracically. Mice were killed at 24 hours, 48 hours, and 72 hours after delivery. Bronchial alveolar lavage was recollected to measure albumin and cytokines by enzyme-linked immunosorbent assay. Pulmonary compliance was measured, and lungs were subject to histopathologic analysis. RESULTS: After the electroporation and delivery of genes coding for the α,β subunits of the Na+/K+-ATPase pump, there was a significant mitigation of acute lung injury as evidenced by reduction in bronchial alveolar lavage levels of albumin, improved pressure volume curves, and reduced inflammation seen on histology. CONCLUSION: Electroporation-mediated gene transfer of the subunits of the Na+/K+-ATPase pump enhanced recovery from acute inflammatory lung injury after LC.
Authors: M Stern; K Ulrich; C Robinson; J Copeland; U Griesenbach; C Masse; S Cheng; F Munkonge; D Geddes; Y Berthiaume; E Alton Journal: Gene Ther Date: 2000-06 Impact factor: 5.250
Authors: Krishnan Raghavendran; Robert H Notter; Bruce A Davidson; Jadwiga D Helinski; Steven L Kunkel; Paul R Knight Journal: Shock Date: 2009-08 Impact factor: 3.454
Authors: J Jason Hoth; Jonathan D Wells; Noel A Brownlee; Elizabeth M Hiltbold; J Wayne Meredith; Charles E McCall; Barbara K Yoza Journal: Shock Date: 2009-04 Impact factor: 3.454
Authors: Jeroen A J Vanoirbeek; Manuela Rinaldi; Vanessa De Vooght; Steven Haenen; Sonja Bobic; Ghislaine Gayan-Ramirez; Peter H M Hoet; Erik Verbeken; Marc Decramer; Benoit Nemery; Wim Janssens Journal: Am J Respir Cell Mol Biol Date: 2009-04-03 Impact factor: 6.914
Authors: Krishnan Raghavendran; Bruce A Davidson; Paul R Knight; Zhengdong Wang; Jadwiga Helinski; Patricia R Chess; Robert H Notter Journal: Shock Date: 2008-11 Impact factor: 3.454
Authors: Yue Yang; Min Dai; Teresa M Wilson; Irina Omelchenko; John E Klimek; Phillip A Wilmarth; Larry L David; Alfred L Nuttall; Peter G Gillespie; Xiaorui Shi Journal: PLoS One Date: 2011-01-31 Impact factor: 3.240
Authors: Vladislav A Dolgachev; Bi Yu; Lei Sun; Thomas P Shanley; Krishnan Raghavendran; Mark R Hemmila Journal: Shock Date: 2014-04 Impact factor: 3.454
Authors: Madathilparambil V Suresh; Sadeesh Kumar Ramakrishnan; Bivin Thomas; David Machado-Aranda; Yu Bi; Nicholas Talarico; Erik Anderson; Shah M Yatrik; Krishnan Raghavendran Journal: Crit Care Med Date: 2014-10 Impact factor: 7.598
Authors: Bryanna M Emr; Shreyas Roy; Michaela Kollisch-Singule; Louis A Gatto; Michael Barravecchia; Xin Lin; Jennifer L Young; Guirong Wang; Jiao Liu; Joshua Satalin; Kathleen Snyder; Gary F Nieman; David A Dean Journal: Shock Date: 2015-01 Impact factor: 3.454
Authors: Madathilparambil V Suresh; Bi Yu; Satyan Lakshminrusimha; David Machado-Aranda; Nicholas Talarico; Lixia Zeng; Bruce A Davidson; Subramaniam Pennathur; Krishnan Raghavendran Journal: Surgery Date: 2013-11 Impact factor: 3.982
Authors: David Machado-Aranda; Madathilparambil V Suresh; Bi Yu; Vladislov Dolgachev; Mark R Hemmila; Krishnan Raghavendran Journal: J Trauma Acute Care Surg Date: 2014-04 Impact factor: 3.313